Berubicin hydrochloride, Cecenu® 40 mg Kapsel
CNS-201
Phase 2 small_molecule active
Quick answer
Berubicin hydrochloride, Cecenu® 40 mg Kapsel for Glioblastoma multiforme (GBM) is a Phase 2 program (small_molecule) at CNS Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CNS Pharmaceuticals
- Indication
- Glioblastoma multiforme (GBM)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active